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We read with great interest the paper by Kadayifci
et al. [1] regarding the prevalence of coronary artery dis-
ease (CAD) and risk factors for atherosclerosis in liver
cirrhosis. The authors reviewed retrospectively the pa-
tient notes of 60 subjects with non-alcoholic steatohepa-
titis (NASH)-related cirrhosis and 60 age- and sex-
matched controls with cirrhosis of other aetiologies
who underwent liver transplantation. The two groups
were compared regarding the prevalence of CAD and
that of risk factors for atherosclerosis. The prevalence
of CAD was found to be higher in NASH-cirrhosis than
in cirrhosis due to other aetiologies (21.6% vs. 3.3%,
p < 0.05). Also, patients with NASH-cirrhosis were
found to have higher prevalence of arterial hypertension
(51.6% vs. 20%), diabetes mellitus (65% vs. 31.6%),
obesity (28.3% vs. 6.6%), and the metabolic syndrome
(48.3% vs. 10%) compared to those with cirrhosis of
other aetiologies (p < 0.05 for all). The two groups did
not diﬀer signiﬁcantly in smoking habits or the presence
of atherosclerosis in hepatic arteries of explanted livers
[1]. The authors concluded that CAD and major risk
factors for atherosclerosis are signiﬁcantly more preva-
lent in subjects with NASH-cirrhosis compared to cir-
rhosis of other aetiologies.
The prevalence of CAD has been considered to be
low among patients with liver cirrhosis compared to
the general population. This notion is based mainly on
autopsy studies since the 1960s and 1970s [2,3] as well
as on studies from the South of Europe in which the
majority of included patients had cirrhosis due to hepa-
titis C [4,5]. Although no formal comparison with a con-
trol population was performed, the study of Kadayifci
et al. suggests that patients with NASH-cirrhosis do
not have a low prevalence of CAD. However, the most
common cause of cirrhosis in Western countries is alco-
holic liver disease (ALD) and, unfortunately, no patients
with ALD-cirrhosis were included in the study by Kad-
ayifci et al. [1]. Comparative data on the prevalence of
CAD and its risk factors in patients with cirrhosis of dif-
ferent aetiologies are largely lacking.
We recently conducted a prospective study on the
prevalence of CAD and its risk factors in 127 consecu-
tive patients with liver cirrhosis compared to a sample
of subjects from the general population (n = 203) [6].
A total of 55/127 patients (43%) had ALD-cirrhosis,
22 (17%) had NASH (or cryptogenic) cirrhosis, and 50
(40%) had cirrhosis of other aetiologies. CAD was
found to be more common in cirrhotic patients com-
pared to controls (20% vs. 12%, p = 0.001). In regression
analysis, CAD was independently related to diabetes
(odds ratio (OR) 5.47, 95% conﬁdence interval (CI)
2.44–12.28), but not to liver cirrhosis. In the liver cirrho-
sis group only ALD-cirrhosis (OR 9.5, 95% CI 1.08–
83.4) and age (OR 1.23 per year, 95% CI 1.06–1.43) were
independently related to CAD [2]. In this study,
although ALD-cirrhosis was more common among cir-
rhotic patients with CAD than in those without CAD
(65% vs. 38%, p = 0.01), the prevalence of NASH-cir-
rhosis did not diﬀer signiﬁcantly between the two groups
(23% vs. 16%, p > 0.05) and, thus, the latter was not en-
tered in the regression analysis [6].
We have now stratiﬁed our cohort according to etiol-
ogy of liver cirrhosis, thus dividing it into three groups:
the ALD-cirrhosis group (n = 55), the NASH-cirrhosis
group (n = 22), and the groups of cirrhosis due to other
aetiologies (n = 50). The prevalence of CAD did not
diﬀer signiﬁcantly between NASH- and ALD-cirrhosis
but was lower in cirrhosis of other aetiologies compared
to both groups (p < 0.05) (Fig. 1). The prevalence of
CAD risk factors is shown in Table 1. Patients with
NASH-cirrhosis were older and had diabetes and his-
tory of arterial hypertension more often than patients
in the other two cirrhosis groups (p < 0.05). ALD-cir-
rhotic patients were more often male and smokers than
patients in the other two groups (p < 0.05). The three
cirrhosis groups did not diﬀer signiﬁcantly in the prev-
alence of obesity, hereditary predisposition to CAD,
cirrhosis complications or severity, or serum cholesterol
(p > 0.05 for all). In multivariate analysis, CAD was
found to be independently related to age (OR 1.1 per yr,
95% CI 1.04–1.2), ALD-cirrhosis (3.5, 95% CI 1.2–10.1),
and history of arterial hypertension (2.9, 95% CI
1.04–8.2).
Taken together, the ﬁndings of Kadayifci et al. [1]
and our results indicate that the prevalence of CAD is
higher in ALD- and NASH-cirrhosis compared to cir-
rhosis of other aetiologies. Both studies show that
CAD risk factors are more common in NASH-cirrhosis
than in cirrhosis of other aetiologies. These results sug-
gest that a more rigorous work-up for the diagnosis of
CAD may be indicated in patients with ALD- and
NASH-cirrhosis.
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Coronary artery disease in NASH-related cirrhosis
To the Editor:
We thank Drs. Kalaitzakis and Bjo¨rnsson [1] for their
interest in our paper [2] and for providing their data that
supports our observation of a high prevalence of coro-
nary artery disease in patients with cirrhosis from non-
alcoholic steatohepatitis (NASH) compared to those
Table 1
Clinical characteristics and risk factors for coronary artery disease in
patients with ALD-cirrhosis, NASH-cirrhosis, and those with cirrhosis of
other etiologies.
NASH-
cirrhosis
(n = 22)
Alcoholic
cirrhosis
(n = 55)
Cirrhosis
of other
etiologies
(n = 50)
p-Value
Age (years) 63 (11) 58 (9) 53 (13) 0.001
Males 41% 75% 54% 0.011
Smoking 59% 80% 54% 0.014
Diabetes 41% 29% 16% 0.067
History of arterial
hypertension
52% 28% 12% 0.002
Obesity
(BMI > 30)
32% 13% 14% 0.104
Hereditary predisposition
for CAD
17% 7% 3% 0.214
Data are presented as mean (standard deviation) or percentage as
appropriate.
The p-value for ANOVA (age) or for chi-square testing (nominal
variables) for all three groups are reported.
SD, standard deviation; CAD, coronary artery disease.
Fig. 1. The prevalence of coronary artery disease in patients with ALD-
cirrhosis, NASH-cirrhosis, and in those with cirrhosis of other etiologies.
The p-value of chi-square test for all three groups is reported. ALD,
alcoholic liver disease; NASH, non-alcoholic steatohepatitis.
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